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For personalCongenital leukemia is a rare disease. The majority of cases of this disease are acute myelog-
enous leukemia (AML). Congenital acute lymphoblastic leukemia (ALL) is rare and most often is
of B cell lineage. Rarely, some cases have been designated biphenotypic or mixed phenotype
acute leukemia (MPAL). Herein, we report a preterm newborn referred to us as a result of the
appearance of blue-violaceous dermal nodules on her body at birth. She was a twin and the
product of an in vitro fertilization (IVF) pregnancy. Physical examination showed jaundice, he-
patosplenomegaly, and peripheral facial nerve palsy in addition to dermal nodules. Bone
marrow aspiration showed 40% blasts of lymphoid lineage; skin biopsy and its immunohisto-
chemistry revealed myeloblastic infiltration of the dermis. Cytogenetic analysis (46,XX), fluo-
rescence in situ hybridization (FISH) analysis, and cranial magnetic resonance were normal.
The patient was diagnosed with congenital MPAL, and an association between IVF and congen-
ital leukemia was suggested.
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272 H. Ergin et al1. Introduction
Leukemia diagnosed from birth to 6 weeks of age is defined
as congenital leukemia.1 Congenital leukemia cases are
fewer than five per 1 million live births, and 80% of cases
are nonlymphoblastic.2 The majority of congenital leuke-
mia cases are acute myelogenous leukemia (AML).3
Congenital acute lymphoblastic leukemia (ALL) is rare and
most often of B cell lineage (B-ALL).3 Rarely, some cases
(around 5%) of leukemias have been designated bipheno-
typic or mixed phenotype acute leukemia (MPAL).4,5
Twenty-five to thirty percent of newborns with leukemia
have leukemia cutis, which is a direct infiltration of skin
and subcutaneous tissue by malignant cells. Leukemia cutis
usually occurs in patients with AML but may also be seen in
ALL.4 Herein, a newborn with congenital MPAL is reported
and an association between in vitro fertilization (IVF) and
congenital leukemia is suggested.
2. Case Report
A 10-day-old female newborn was referred to our hospital
owing to the appearance of blue-violaceous dermal nodules
on her body at birth. The patient was the product of an
uneventful pregnancy induced by IVF because of primary
infertility. She was born by cesarean section following a 35-
week pregnancy as a twin pair to a 24-year-old healthy
mother and her unrelated 29-year-old healthy husband.
Birth weight, length, and head circumference of the pa-
tient were between the 25th and 50th percentiles. Her
brother was healthy. There was no history of maternal
illness, malignancy, smoking, drug and alcohol use, expo-
sure to X-rays or other known teratogens. It was learned
that the mother had consumed just a small amount of tea,
coffee, and cacao during pregnancy. Physical examination
showed jaundice and multiple nonblanchable, firm, blue-
violaceous dermal nodules, 3e10 mm in diameter, on her
scalp, face, neck, chest, abdomen, back, buttocks, and
extremities (Figure 1). The oral and ocular mucosa, palms,
and soles were not affected. Petechiae/ecchymoses were
absent. Liver and spleen were palpable 4 cm and 2 cm
under the midclavicular line of the costa, respectively. No
dysmorphic features were noted. Bilateral fundoscopicFigure 1 The appearance of dermal nodules.
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peripheral facial nerve palsy was determined.
The initial complete blood count showed a white blood
cell count of 10.200/mm3, hemoglobin 12.2 g/dL, and a
platelet count of 51.000/mm3. A peripheral blood smear
demonstrated circulating blasts (19%), while a bone marrow
aspiration showed approximately 40% blasts of lymphoid
lineage (Figure 2). Periodic acid Schiff and myeloperoxidase
(MPO) stains were negative. Bone marrow flow cytometry
showed surface cluster of differentiation 45 (CD45) 85.4%,
CD3 62.8%, CD5 63.7%, and CD7 68.3%, while other markers
[CD10, CD13, CD15, CD19, CD20, CD22, CD33, CD34, CD79a,
CD117, terminal deoxynucleotidyl transferase (Tdt), and
human leucocyte antigen-DR (HLA-DR)] were negative. A
skin biopsy specimen demonstrated a dense papillary
dermis and perivascular infiltrate composed of relatively
uniform large neoplastic cells with round to oval nuclei,
distinct nucleoli, and little basophilic cytoplasm. The
epidermis was intact and a grenz zone was present under
the epidermis. Dermal adnexes and subcutis were not
involved. Immunohistochemistry of the skin biopsy spec-
imen revealed myeloblastic infiltration with CD34 and MPO
positive (Figure 3), whereas TdT/CD117/S-100 and CD1a
were negative. The present patient was diagnosed with
congenital mixed phenotype acute leukemia according to
the World Health Organization (WHO) 2008 classification
because CD3 was shown positive (by bone marrow flow
cytometry, T-lymphoid lineage) and MPO was shown posi-
tive (by immunohistochemistry, myeloid lineage).5 Cyto-
genetic analysis performed from a peripheral blood sample
showed a normal female karyotype. There were no abnor-
malities in chromosome 21 or 11q23 region on 20 cells and
five cells karyotyped, respectively. Fluorescence in situ
hybridization (FISH) analysis was performed with an 11q23
region probe (LSI/MLL/DC/BAR-Vysis) and chromosome 7
(LSI/D7S522/CEP7-Vysis). The FISH results for trans-
locations or deletions involving the MLL gene and for
monosomy 7 or 7q deletions were negative. Serum trans-
aminases and cranial magnetic resonance imaging were
normal. Examination of cerebrospinal fluid cytology was
free of malignant cells. Blood cultures and serum antibody
titers against TORCH infections were negative. TotalFigure 2 The bone marrow smear showing lymphoblastic
cells (Wright’s stain, 100).
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Figure 3 The myeloperoxidase (MPO) stain is positive in the
neoplastic cells on the dermal infiltration (MPO, 400).
Newborn congenital mixed phenotype acute leukemia 273bilirubin level was 16.2 mg/dL. Blood group incompatibility,
glucose-6-phosphate dehydrogenase deficiency, hereditary
spherocytosis, and hypothyroidism were not detected. The
Interfant-99 protocol [induction phase including prednisone
60 mg/m2 daily intravenous (IV) within the 1st week of
hospitalization; dexamethasone 6 mg/m2 daily IV from 8
days to 15 days; vincristine 15 mg/m2 IV on the 8th day;
cytarabine 75 mg/m2 daily IV from 8 days to 15 days; and
daunorubicin 30 mg/m2 IV on the 8th and 9th days] was
administered to the patient for MPAL. However, she died
because of massive gastrointestinal hemorrhage on the 15th
day following initiation of chemotherapy.
3. Discussion
The etiology of congenital leukemia is unknown.1 However,
several factors may be associated with the development of
leukemia in the newborn period. These include maternal
exposure to radiation, high birth weight (>4000 g), and high
levels of insulin-like growth factors as well as exposure to
topoisomerase-II inhibitors, suchas coffee, tea, cocoa,wine,
and soy products.6 In this study, there were no leukemia-
associated factors except for maternal consumption of
small amounts of tea, coffee, and cacao during pregnancy.
The clinical features of congenital leukemia include
nodular skin infiltrates, hepatosplenomegaly, lethargy, poor
feeding, pallor, purpura/petechiae, and respiratory
distress.1 The present patient had only nodular skin in-
filtrates and hepatosplenomegaly. The diagnosis of congen-
ital leukemia includes proliferation of immature leucocytes,
infiltration of these cells into the extra hematopoietic tissue,
absence of disease that can cause leukemoid or leukoery-
throblastic reactions such as congenital infection, ABO in-
compatibility, and absence of chromosomal disorders that
may be associated with unstable hematopoiesis, such as
trisomy 21.3 Our patient fulfilled all these criteria.
Leukemia cutis may be the first manifestation of
congenital leukemia.7,8 It presents as firm erythematous or
blue-violaceous macules, papules, and nodules as a result
of infiltrating leukemic cells in the skin.8 Leukemia cutis is
cited as occurring in 25e30% of patients. These lesions are
observed most commonly in AML but may also be seen inDownloaded for Anonymous User (n/a) at Pamukkale Universi
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a generalized pattern. Involvements of oral and ocular
mucosa are quite rare.8 There were widespread blue-
violaceous dermal nodules on our patient’s body except
on the oral/ocular mucosa, palms, and soles.
Although a few cases with spontaneous remission have
been described, congenital leukemia has a poor prog-
nosis.3,8,9 When congenital AML and ALL were compared,
clinical characteristics and overall survival were not found
to be significantly different.9 Our patient died after a few
days of the chemotherapy.
The classification of acute leukemias is based on a com-
bination of morphology and cytochemical staining.5 In most
cases, the cells are of myeloid or lymphoid origin. However,
in approximately 5% of cases, a single blast population
coexpressesmyeloid and lymphoid antigens. These cases are
designated as acute biphenotypic leukemia, hybrid or mixed
lineage leukemia.4 Bilineage leukemia is defined as two
different lineages of leukemic cell population in the same
patient at the same time.10 This type of leukemia, formerly
designated as “bilineal acute leukemia” and “biphenotypic
acute leukemia”, is nowcollectively considered tobe“mixed
phenotype acute leukemia”.5 CD3 positive for T-lymphoid
lineage by bonemarrow flow cytometry and MPO positive for
myeloid lineage by immunohistochemistry of skin biopsy
specimenwere determined in the present patient. According
to the WHO 2008 classification, the present patient was
diagnosed as MPAL. To our knowledge, this neonatal case
report is the first case of congenital MPAL in the literature.
Chromosomal instability is a hallmark of congenital leuke-
mia. The most commonly involved gene in infant leukemia is
MLL, which encodes a 431-kDa protein. The most common
translocations involving MLL are the t(4;11) and t(11;19) in
ALL, and the t(9;11), t(6;11), and t(11;19) in AML.11 There
were no (LSI/MLL/DC/BAR-Vysis) deletions or translocations
or monozomy 7 and 7q deletions (LSI/D7S522/CEP7-Vysis) in
our patient.
Although IVF is not considered to be associated with an
increased risk of pediatric malignancies, some cases with
neuroectodermal tumors (neuroblastoma and medulloblas-
toma), embryonal cancers (hepatoblastoma and renal clear
cell sarcoma), and retinoblastoma born after IVF have been
reported.12e15 Enhanced ovulation and spermatogenesis
induced by various hormonal treatments, various manipula-
tions performed on the germ cells and the fertilized ovum,
and preservation of pregnancy by progestational hormones
are prone to carcinogenic effects in these pregnancies.14 A
possible association between IVF and congenital leukemia
may be suggested in the presented patient, who did not have
any environmental, prenatal, or familial risk factors.
In conclusion, it should be kept in mind that skin nodules
in a newborn may be a presenting sign of malignancy, and
that the evaluation of these newborns using laboratory
studies, peripheral blood smear, bone marrow aspiration,
serologies, cytogenetics, and skin biopsy must be per-
formed as soon as possible.References
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